HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 63/284,884
Filed on 2021-12-01
Filed on 2021-12-01
COMBINATION IMMUNOTHERAPY FOR TREATING CANCER
US Application 63/309,826
Filed on 2022-02-14
Filed on 2022-02-14
Autosomal Mosaicism Detected In Blood Cell DNA Of Healthy Individuals Predicts Post-cancer Diagnosis Infection Risk
US Application 63/093,579
Filed on 2020-10-19
Filed on 2020-10-19
BACTERIOPHAGE LAMBDA-VACCINE SYSTEM
US Application 63/289,018
Filed on 2021-12-13
Filed on 2021-12-13
IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF
US Application 63/277,287
Filed on 2021-11-09
Filed on 2021-11-09
Single Domain Antibodies Targeting The S2 Subunit Of SARS-CoV-2 Spike Protein
US Application 63/271,854
Filed on 2021-10-26
Filed on 2021-10-26
Methods And Materials For Large-Scale Assessment Of Ligand Binding Selectivity Of G-Quadruplex Recognition Using Custom G4 Microarrays
US Application 63/016,385
Filed on 2020-04-28
Filed on 2020-04-28
COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER
US Application 63/208,719
Filed on 2021-06-09
Filed on 2021-06-09
FIBP Knockout In T Cells Amplifies Antitumor Activity By Limiting Cholesterol Metabolism, Suggesting A Potentiator Of Adoptive Cell Therapy
US Application 63/246,743
Filed on 2021-09-21
Filed on 2021-09-21
LZK INHIBITORS AND METHODS OF USE
US Application 63/239,797
Filed on 2021-09-01
Filed on 2021-09-01